New drug study aims to tailor breast cancer treatment for chinese women

NCT ID NCT02499146

First seen Nov 01, 2025 · Last updated Apr 26, 2026 · Updated 23 times

Summary

This study looked at how the drug palbociclib works in Chinese women with a certain type of advanced breast cancer. 26 postmenopausal women took the drug, and researchers measured its levels in the body and checked for side effects. The goal was to gather information for Chinese health authorities, not to cure the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Beijing Cancer Hospital/Oncology department

    Beijing, Beijing Municipality, 100142, China

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Beijing, 100021, China

  • Guangdong General Hospital/Department of Breast Surgery

    Guangzhou, Guangdong, 510080, China

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, 150081, China

  • Sun Yat-Sen University Cancer Center

    Guangzhou, Guangdong, 510060, China

  • The First Affiliated Hospital of College of Medicine, Zhejiang University

    Hangzhou, Zhejiang, 310003, China

  • The first hospital of jilin university

    Changchun, Jilin, 130021, China

Conditions

Explore the condition pages connected to this study.